Xiong Y - Search Results

1

Preparation and Quality Evaluation of Honokiol Nanoparticles Using a New Polysaccharide Polymer as its Carrier.

Weng Y, Zhang H, Xu S, Zhao Y, Ma L, Shi J, Qian K, Liang W, Xiong Y. Weng Y, et al. Among authors: xiong y. Curr Drug Deliv. 2023;20(2):183-191. doi: 10.2174/1567201819666220607153457. Curr Drug Deliv. 2023. PMID: 35674293

2

Improving Topical Skin Delivery of Monocrotaline Via Liposome Gel-based Nanosystems.

Yu J, Chen Z, Yin YZ, Tang C, Hu E, Zheng S, Liu Q, Xiong Y. Yu J, et al. Among authors: xiong y. Curr Drug Deliv. 2019;16(10):940-950. doi: 10.2174/1567201816666191029125300. Curr Drug Deliv. 2019. PMID: 31660816

3

The Application of Chemometrics for Efficiency Enhancement and Toxicity Reduction in Cancer Treatment with Combined Therapy.

Qian K, Yan B, Xiong Y. Qian K, et al. Among authors: xiong y. Curr Drug Deliv. 2021;18(6):679-687. doi: 10.2174/1567201817999200817152235. Curr Drug Deliv. 2021. PMID: 32811399 Review.

4

Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.

Qian K, Tang CY, Chen LY, Zheng S, Zhao Y, Ma LS, Xu L, Fan LH, Yu JD, Tan HS, Sun YL, Shen LL, Lu Y, Liu Q, Liu Y, Xiong Y. Qian K, et al. Among authors: xiong y. ACS Omega. 2021 Apr 13;6(16):10645-10654. doi: 10.1021/acsomega.0c06288. eCollection 2021 Apr 27. ACS Omega. 2021. PMID: 34056218 Free PMC article.

5

Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy.

Zhang H, Yu J, Ma L, Zhao Y, Xu S, Shi J, Qian K, Gu M, Tan H, Xu L, Liu Y, Mu C, Xiong Y. Zhang H, et al. Among authors: xiong y. Int J Pharm. 2022 Aug 25;624:121931. doi: 10.1016/j.ijpharm.2022.121931. Epub 2022 Jun 21. Int J Pharm. 2022. PMID: 35750278

6

Pharmacokinetics of ginkgolide B-lyophilized nanoparticles after intravenous injection in rats using liquid chromatography-tandem mass spectrometry.

Ma L, Zhu L, Peng J, Xu S, Zhao Y, Shi J, Liu Q, Zhang H, Li J, Xiong Y. Ma L, et al. Among authors: xiong y. Rapid Commun Mass Spectrom. 2023 Mar 30;37(6):e9465. doi: 10.1002/rcm.9465. Rapid Commun Mass Spectrom. 2023. PMID: 36581608

7

Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOX^Fluc Cells.

Zhao Y, Tang C, Huang J, Zhang H, Shi J, Xu S, Ma L, Peng C, Liu Q, Xiong Y. Zhao Y, et al. Among authors: xiong y. ACS Omega. 2023 Jan 23;8(5):4853-4861. doi: 10.1021/acsomega.2c07096. eCollection 2023 Feb 7. ACS Omega. 2023. PMID: 36777569 Free PMC article.

8

Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy.

Zhang H, Chen L, Zhao Y, Luo N, Shi J, Xu S, Ma L, Wang M, Gu M, Mu C, Xiong Y. Zhang H, et al. Among authors: xiong y. Asian J Pharm Sci. 2023 Mar;18(2):100796. doi: 10.1016/j.ajps.2023.100796. Epub 2023 Feb 25. Asian J Pharm Sci. 2023. PMID: 37008735 Free PMC article.

9

Delivering Relaxin Plasmid by Polymeric Metformin Lipid Nanoparticles for Liver Fibrosis Treatment.

Li Y, Ma L, Xiong Y, Shi J, Zhang F, Chai Q, Hu G, Liu Y. Li Y, et al. Among authors: xiong y. Curr Drug Deliv. 2024;21(3):431-437. doi: 10.2174/1567201820666230407135026. Curr Drug Deliv. 2024. PMID: 37032506

10

Integrated animal experiments and network pharmacology for investigating therapeutic effect of celastrol-loaded liposomes on NAFLD.

Shi J, Ma N, Luo N, Huang J, Xu S, Xiong Y. Shi J, et al. Among authors: xiong y. Curr Drug Deliv. 2023 Aug 10. doi: 10.2174/1567201821666230810094643. Online ahead of print. Curr Drug Deliv. 2023. PMID: 37565560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,134 results

Search Page

Filters